| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/01/2023 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 771 | $10.50 | $8.1k | | 08/01/2023 |
| 01/27/2023 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Option to Purchase Common Stock | 20k | $18.40 | $368k | | 01/27/2023 |
| 01/27/2023 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Common Stock | 12.2k | $0.00 | $0 | | 01/27/2023 |
| 12/31/2022 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 718 | $12.37 | $8.9k | | 12/31/2022 |
| 08/01/2022 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 771 | $12.21 | $9.4k | | 08/01/2022 |
| 05/01/2022 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 771 | $15.71 | $12.1k | | 05/01/2022 |
| 01/27/2022 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Option to Purchase Common Stock | 17.6k | $14.44 | $254.1k | | 01/27/2022 |
| 01/27/2022 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Common Stock | 10.3k | $0.00 | $0 | | 01/27/2022 |
| 02/01/2021 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Option to Purchase Common Stock | 69.4k | $36.90 | $2.6M | | 02/01/2021 |
| 02/01/2021 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Common Stock | 44.3k | $0.00 | $0 | | 02/01/2021 |
| 10/23/2020 | IMMUNOMEDICS INC | IMMU | Disposition | Stock Option (Right to Buy) | 280.1k | $0.00 | $0 | | 10/23/2020 |
| 03/04/2020 | IMMUNOMEDICS INC | IMMU | Grant | Stock Option (right to buy) | 51.6k | $17.16 | $885.5k | | 03/04/2020 |
| 09/06/2019 | IMMUNOMEDICS INC | IMMU | Grant | Stock Option (right to buy) | 67.5k | $13.19 | $890.1k | | 09/06/2019 |
| 03/14/2019 | IMMUNOMEDICS INC | IMMU | Grant | Stock Option (right to buy) | 13.8k | $17.94 | $247.2k | | 03/14/2019 |
| 03/14/2019 | IMMUNOMEDICS INC | IMMU | Grant | Stock Option (right to buy) | 27.6k | $17.94 | $494.4k | | 03/14/2019 |
| 09/24/2018 | IMMUNOMEDICS INC | IMMU | Grant | Stock Option (right to buy) | 119.7k | $21.72 | $2.6M | | 09/24/2018 |